博迅生物
(920504)
| 流通市值：3.69亿 | | | 总市值：9.36亿 |
| 流通股本：1709.19万 | | | 总股本：4333.31万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 33,037,871.05 | 75,724,878.33 | 42,126,073.58 | 29,676,167.4 |
| 交易性金融资产 | 59,994,184.49 | 35,162,694.96 | 30,097,399.7 | 65,062,356.64 |
| 应收票据及应收账款 | 21,746,080.61 | 9,662,371.56 | 29,396,726.02 | 26,752,996.05 |
| 其中：应收票据 | 4,782,966.42 | 7,503,575.08 | 5,347,799.71 | 3,317,095.03 |
| 应收账款 | 16,963,114.19 | 2,158,796.48 | 24,048,926.31 | 23,435,901.02 |
| 应收款项融资 | 480,901.46 | 4,050,168.68 | 1,500,037.58 | 958,673.17 |
| 预付款项 | 1,554,681.61 | 1,159,783.09 | 1,232,504.82 | 1,184,353.03 |
| 其他应收款合计 | 191,864 | 102,493.16 | 196,001.69 | 173,411.74 |
| 其中:应收利息 | - | - | 76,487.69 | 51,534.26 |
| 存货 | 31,355,240.53 | 30,543,462.33 | 25,092,883.74 | 25,846,548.71 |
| 一年内到期的非流动资产 | 11,965,837.46 | 11,913,273.71 | 1,260,352.12 | 1,260,352.12 |
| 其他流动资产 | 3,631,063.6 | 3,358,514.55 | 20,604,244.86 | 2,565,205.34 |
| 流动资产合计 | 163,957,724.81 | 171,677,640.37 | 151,506,224.11 | 153,480,064.2 |
| 非流动资产: | | | | |
| 长期应收款 | 14,813,969.03 | 14,695,622.42 | 15,829,541.21 | 15,699,602.5 |
| 固定资产 | 24,255,467.67 | 24,938,182.73 | 22,042,337.14 | 22,601,341.63 |
| 在建工程 | 25,641,830.97 | 25,641,830.97 | 22,707,719.61 | 20,733,645.68 |
| 使用权资产 | 3,062,584.74 | 3,108,294.96 | 4,246,181.08 | 4,478,053.9 |
| 无形资产 | 9,442,302.74 | 9,549,418.04 | 9,675,644.84 | 9,730,974.9 |
| 长期待摊费用 | 7,471,153.34 | 7,872,629.39 | 3,547,998.27 | 2,715,665.12 |
| 递延所得税资产 | 3,547,064.39 | 3,788,148.7 | 4,101,923.33 | 3,968,031.42 |
| 其他非流动资产 | 10,139,808.23 | 10,088,027.4 | 21,378,585.65 | 11,874,057.93 |
| 非流动资产合计 | 98,374,181.11 | 99,682,154.61 | 103,529,931.13 | 91,801,373.08 |
| 资产总计 | 262,331,905.92 | 271,359,794.98 | 255,036,155.24 | 245,281,437.28 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 22,384,690.82 | 25,444,817.1 | 15,767,697.17 | 16,777,511.41 |
| 应付账款 | 22,384,690.82 | 25,444,817.1 | 15,767,697.17 | 16,777,511.41 |
| 合同负债 | 2,111,343.79 | 4,219,853.88 | 2,356,769.39 | 1,494,872.25 |
| 应付职工薪酬 | 2,283,166.74 | 5,490,571.38 | 2,888,527.3 | 2,449,613.02 |
| 应交税费 | 838,870.7 | 1,822,726.22 | 2,504,507.67 | 1,747,633.75 |
| 其他应付款合计 | 2,096,284.81 | 4,366,493.01 | 3,604,555.63 | 2,403,833.35 |
| 一年内到期的非流动负债 | 731,830.37 | 726,618.49 | 2,359,242.69 | 2,354,629.07 |
| 其他流动负债 | 5,212,266.15 | 4,140,807.37 | 5,513,596.62 | 2,881,709.8 |
| 流动负债合计 | 35,658,453.38 | 46,211,887.45 | 34,994,896.47 | 30,109,802.65 |
| 非流动负债: | | | | |
| 租赁负债 | 17,121,955.92 | 16,994,603.96 | 17,950,114.29 | 17,801,462.96 |
| 递延收益 | 1,633,337 | 1,733,336 | 1,888,085 | 2,042,834 |
| 递延所得税负债 | 16,239.56 | 13,669.52 | 167,701.62 | 199,357.94 |
| 非流动负债合计 | 18,771,532.48 | 18,741,609.48 | 20,005,900.91 | 20,043,654.9 |
| 负债合计 | 54,429,985.86 | 64,953,496.93 | 55,000,797.38 | 50,153,457.55 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 43,333,100 | 43,333,100 | 43,333,100 | 43,333,100 |
| 资本公积 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 |
| 盈余公积 | 20,213,544.1 | 20,213,544.1 | 18,611,085.85 | 18,611,085.85 |
| 未分配利润 | 29,765,144.3 | 28,269,522.29 | 23,501,040.35 | 18,593,662.22 |
| 归属于母公司股东权益合计 | 207,901,920.06 | 206,406,298.05 | 200,035,357.86 | 195,127,979.73 |
| 股东权益合计 | 207,901,920.06 | 206,406,298.05 | 200,035,357.86 | 195,127,979.73 |
| 负债和股东权益合计 | 262,331,905.92 | 271,359,794.98 | 255,036,155.24 | 245,281,437.28 |
| 公告日期 | 2026-04-28 | 2026-03-30 | 2025-10-30 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |